Dolph Houben

25 Introduction and Outline of the Thesis 1 60. Petruzzo, P., M. Lanzetta, J.M. Dubernard, et al., The International Registry on Hand and Composite Tissue Transplantation. Transplantation, 2010. 90 (12): p. 1590-4. 61. Chiron, P., J.A. Colombier, J.L. Tricoire, et al., [A large vascularized allograft of the femoral diaphysis in man]. [French]. International Orthopaedics, 1990. 14 (3): p. 269-72. 62. Doi, K., S. Kawai, and M. Shigetomi, Congenital tibial pseudoarthrosis treated with vascularised bone allograft. Lancet, 1996. 347 (9006): p. 970-1. 63. Hofmann, G.O. and M.H. Kirschner, Clinical experience in allogeneic vascularized bone and joint allografting. Microsurgery, 2000. 20 (8): p. 375-83. 64. Diefenbeck, M., F. Wagner, M.H. Kirschner, et al., Outcome of allogeneic vascularized knee transplants. Transplant International, 2007. 20 (5): p. 410-8. 65. Diefenbeck, M., F. Wagner, M.H. Kirschner, et al., Management of acute rejection 2 years after allogeneic vascularized knee joint transplantation. Transplant International, 2006. 19 (7): p. 604-6. 66. Hofmann, G., M.H. Kirschner, F.D. Wagner, et al., Allogeneic vascularized transplantation of human femoral diaphyses and total knee joints--first clinical experiences. Transplant Proc, 1998. 30 (6): p. 2754-61. 67. Hofmann, G.O., C. Falk, and T. Wangemann, Immunological transformations in the recipient of grafted allogeneic human bone. Archives of Orthopaedic & Trauma Surgery, 1997. 116 (3): p. 143-50. 68. Hofmann, G.O., M.H. Kirschner, L. Brauns, et al., Vascularized knee joint transplantation in man: a report on the first cases. Transplant International, 1998. 11 (1). 69. Hofmann, G.O., M.H. Kirschner, V. Buhren, et al., Allogenic vascularized transplantation of a human femoral diaphysis under cyclosporin A immunosuppression. Transpl Int, 1995. 8 (5): p. 418-9. 70. Hofmann, G.O., M.H. Kirschner, F.D. Wagner, et al., Allogeneic vascularized grafting of human knee joints under postoperative immunosuppression of the recipient. World J Surg, 1998. 22 (8): p. 818-23. 71. Hofmann, G.O., M.H. Kirschner, T. Wangemann, et al., Infections and immunological hazards of allogeneic bone transplantation. Arch Orthop Trauma Surg, 1995. 114 (3): p. 159-66. 72. Siu, J.H.Y., V. Surendrakumar, J.A. Richards, et al., T cell Allorecognition Pathways in Solid Organ Transplantation. Front Immunol., 2018. 9:2548. (doi): p. 10.3389/fimmu.2018.02548. eCollection 2018. 73. Helbert, M., Lymphocyte Activation in Immunology for Medical Students . 2016, Elsevier p. 69-76. 74. Karam, S. and R.K. Wali, Current State of Immunosuppression: Past, Present, and Future. Crit Rev Eukaryot Gene Expr, 2015. 25 (2): p. 113-34. 75. Siemionow, M. and C. Ozturk, An update on facial transplantation cases performed between 2005 and 2010. Plast Reconstr Surg., 2011. 128 (6): p. 707e-20e. doi: 10.1097/PRS.0b013e318230c77b. 76. Shores, J.T., V. Malek, W.P.A. Lee, et al., Outcomes after hand and upper extremity transplantation. J Mater Sci Mater Med., 2017. 28 (5): p. 72. doi: 10.1007/s10856-017-5880-0. Epub 2017 Mar 30. 77. Etra, J.W., G. Raimondi, andG. Brandacher, Mechanisms of rejection in vascular composite allotransplantation. Curr Opin Organ Transplant., 2018. 23 (1): p. 28-33. doi: 10.1097/MOT.0000000000000490. 78. Murray, J.E., Organ transplantation (skin, kidney, heart) and the plastic surgeon. Plast Reconstr Surg., 1971. 47 (5): p. 425-31. 79. Gudemez, E., M. Turegun, J. Zins, et al., Microvascular permeability following composite tissue transplantation. Annals of Plastic Surgery, 1998. 41 (5): p. 519-29. 80. Dunn, D.L., Problems related to immunosuppression. Infection and malignancy occurring after solid organ transplantation. Crit Care Clin, 1990. 6 : p. 955. 81. Penn, I., De novo malignances in pediatric organ transplant recipients. Pediatr Transplant, 1998. 2 (1): p. 56-63. 82. Billingham, R.E., L.B. Brent, and P.B. Medawar, Actively acquired tolerance of foreign cells. Nature, 1953. 172 : p. 603.